Palisade Bio Inc.
PALI | NASDAQ
$1.65
-$0.04 (-2.37%)
Sep 22, 2026, 11:20 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | n/a | n/a | 250K | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | 146K |
Gross Profit | n/a | n/a | 250K | n/a | n/a | -146K |
Operating Income | -18.06M | -14.86M | -13.07M | -15.72M | -41.85M | -9.3M |
Interest Income | n/a | n/a | n/a | 13K | n/a | n/a |
Pretax Income | -16.78M | -14.44M | -12.3M | -14.26M | -26.62M | -10.32M |
Net Income | -16.78M | -14.44M | -12.3M | -14.26M | -26.62M | -10.32M |
Selling & General & Admin | 7.86M | 5.8M | 6.2M | 8.76M | 9.31M | 6.05M |
Research & Development | 10.19M | 9.06M | 6.89M | 6.55M | 2.43M | 3.1M |
Other Expenses | n/a | n/a | 225K | 410K | 30.12M | n/a |
Operating Expenses | 18.06M | 14.86M | 13.32M | 15.72M | 41.85M | 9.15M |
Interest Expense | 10K | 12K | 15K | 13K | 2.4M | 235K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 18.06M | 14.86M | 13.32M | 15.72M | 41.85M | 9.3M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 55.67M | 1.42M | 456.01K | 880.1K | 12.41K | 832.31K |
Shares Outstanding (Diluted) | 55.67M | 1.42M | 456.01K | 880.31K | 12.46K | 237.39K |
EPS (Basic) | -0.30 | -10.19 | -27.01 | -16.53 | -2.14K | -186 |
EPS (Diluted) | -0.30 | -10.19 | -27.01 | -16.53 | -2.55K | -186 |
EBITDA | -16.77M | -14.42M | -12.28M | -14.24M | -24.22M | -9.94M |
EBIT | -16.77M | -14.43M | -12.29M | -14.25M | -24.22M | -10.09M |
Depreciation & Amortization | 3K | 3K | 4K | 3K | 2K | 146K |
Add to Watchlist
Select watchlists to add or remove PALI